ES2054327T3 - Sintesis de derivados de manojirimicina. - Google Patents

Sintesis de derivados de manojirimicina.

Info

Publication number
ES2054327T3
ES2054327T3 ES90870141T ES90870141T ES2054327T3 ES 2054327 T3 ES2054327 T3 ES 2054327T3 ES 90870141 T ES90870141 T ES 90870141T ES 90870141 T ES90870141 T ES 90870141T ES 2054327 T3 ES2054327 T3 ES 2054327T3
Authority
ES
Spain
Prior art keywords
homomannojirimycin
epi
configuration
alpha
manojirimicina
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90870141T
Other languages
English (en)
Inventor
George William John Fleet
Ian Bruce
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Monsanto Co
Original Assignee
Monsanto Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Monsanto Co filed Critical Monsanto Co
Application granted granted Critical
Publication of ES2054327T3 publication Critical patent/ES2054327T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

(ALFA)-HOMOMANOJIRIMICINA (1) Y 6-EPI-HOMOMANOJIRIMICINA (2) SON CADA UNA SINTETIZADAS DEL 2-AZIDO-2-DEOXI-3,4:6,7-DI-O-ISOPROPILIDENO-D-GLICERO-DTALO-HEPTONO-1,5-LACTONA (3) EN LA CUAL LA CADENA DE ACETONIDA LATERAL SE HIDROLIZA PARA DAR EL DIOL CORRESPONDIENTE QUE SERA ENTONCES PROTEGIDO CON UN AGENTE PROTECTOR SILIL PARA FORMAR UN ETER SILIL. EL ULTIMO COMPUESTO SE UTILIZA COMO UN INTERMEDIARIO DIVERGENTE EN EL QUE SE FORMA EL ANILLO DE PIPERIDINA UNIENDO LA FUNCION DEL NITROGENO CON C-02 A C-6 (A) CON INVERSION DE LA CONFIGURACION EN C-6 PARA FORMAR 6-EPI-HOMOMANOJIRIMICINA O (B) CON RETENCION DE LA CONFIGURACION EN C-6 PARA FORMAR (ALFA)HOMOMANOJIRIMICINA.
ES90870141T 1989-10-11 1990-09-04 Sintesis de derivados de manojirimicina. Expired - Lifetime ES2054327T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/419,806 US5011929A (en) 1989-05-15 1989-10-11 Synthesis of mannojirimycin derivatives

Publications (1)

Publication Number Publication Date
ES2054327T3 true ES2054327T3 (es) 1994-08-01

Family

ID=23663839

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90870141T Expired - Lifetime ES2054327T3 (es) 1989-10-11 1990-09-04 Sintesis de derivados de manojirimicina.

Country Status (8)

Country Link
US (1) US5011929A (es)
EP (1) EP0427694B1 (es)
JP (1) JP2942606B2 (es)
AT (1) ATE105283T1 (es)
CA (1) CA2024843C (es)
DE (1) DE69008668T2 (es)
DK (1) DK0427694T3 (es)
ES (1) ES2054327T3 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5210089A (en) * 1992-02-04 1993-05-11 Monsanto Company D-rhamnono-1,5-lactone
US5250703A (en) * 1992-09-29 1993-10-05 Monsanto Company Pyrrolidin-3,4-diol derivatives of heptitols and preparation thereof
ATE382351T1 (de) 1999-08-10 2008-01-15 Univ Oxford Langkettige n-alkyl verbindungen und deren oxa- derivate zur verwendung als anitvirale mittel
US7256005B2 (en) 1999-08-10 2007-08-14 The Chancellor, Masters And Scholars Of The University Of Oxford Methods for identifying iminosugar derivatives that inhibit HCV p7 ion channel activity
KR100665194B1 (ko) * 2005-08-30 2007-01-04 주식회사 한림전자 전자부품 솔더용 고정홀더
EP2399587A1 (en) 2006-08-02 2011-12-28 The University of Oxford Liposome treatment of viral infections
CA2666814A1 (en) * 2006-08-21 2008-05-29 United Therapeutics Corporation Combination therapy for treatment of viral infections
EP2282723A2 (en) * 2008-03-26 2011-02-16 University of Oxford Endoplasmic reticulum targeting liposomes
EP2410989A2 (en) * 2009-03-27 2012-02-01 The Chancellor, Masters and Scholars of the University of Oxford Cholesterol level lowering liposomes

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3024901A1 (de) * 1980-07-01 1982-01-28 Bayer Ag, 5090 Leverkusen Herbizide mittel auf basis von piperidin-derivaten
US4357360A (en) * 1980-11-13 1982-11-02 International Flavors & Fragrances Inc. Use of tricyclic alcohols, ethers and esters for augmenting or enhancing the aroma or taste of foodstuffs
DE3737523A1 (de) * 1987-11-05 1989-05-18 Bayer Ag Verwendung von substituierten hydroxypiperidinen als antivirale mittel

Also Published As

Publication number Publication date
EP0427694B1 (en) 1994-05-04
DK0427694T3 (da) 1994-06-13
EP0427694A1 (en) 1991-05-15
CA2024843C (en) 2001-11-20
DE69008668T2 (de) 1994-11-24
JP2942606B2 (ja) 1999-08-30
JPH03127775A (ja) 1991-05-30
CA2024843A1 (en) 1991-04-12
US5011929A (en) 1991-04-30
DE69008668D1 (de) 1994-06-09
ATE105283T1 (de) 1994-05-15

Similar Documents

Publication Publication Date Title
IL89921A0 (en) 1,3-dioxolane derivatives and pharmaceutical compositions containing the same
DE69010139D1 (de) Haarkräftigungsmittel.
BR1100762A (pt) Compostos de xantina
ES2090048T3 (es) Derivados de xantina.
FI891176A0 (fi) Peptidfoereningar, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandningar.
NZ240230A (en) Mercaptoacetylamide derivatives; preparation, use and pharmaceutical compositions thereof
ES2077138T3 (es) Derivados de aminocumarano, su produccion y su uso.
NO2011026I2 (no) Eribulin eller et farmasøytisk akseptabelt salt derav
NO180011C (no) Cykliske fruktopyranosesulfitter og -sulfater med antikonvulsiv effekt, farmasöytiske preparater inneholdende slike forbindelser samt mellomprodukter
ES2054327T3 (es) Sintesis de derivados de manojirimicina.
ES8604604A1 (es) Un procedimiento para la produccion de 3,3",4"-tri-o-acilespiramicina i"-.
ES2061724T3 (es) Derivados de sacarido.
ATE90685T1 (de) Disaccharidderivate.
DE69023559D1 (de) Derivate von Muramyldipeptid.
DK638787D0 (da) Anthracyclinderivater, deres fremstilling og anvendelse
FI901277A0 (fi) 2,5,6,7-tetranor-4,8-inter-m-fenylen pg1z-derivativ.
FR2378518A1 (fr) Nouveaux medicaments a base de derives de tetrahydrodibenzopyranne
ES2064652T3 (es) Derivados de naftaleno- y tetrahidronaftaleno-gem-difosfonato.
ES2106199T3 (es) Derivado de nitroxialquilamida.
DE3783821D1 (de) Tetracyclische indolderivate.
ITNA920060V0 (it) Dispositivo antinfortunistico per cacciavite atto ad impedire la fuoriuscita della punta dallo spacco, portato dalla testa delle viti, durante ol lavoro,
FI905922A0 (fi) Antagonister foer a-adrenerga receptorer.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 427694

Country of ref document: ES